tacrolimus and halometasone

tacrolimus has been researched along with halometasone* in 2 studies

Trials

2 trial(s) available for tacrolimus and halometasone

ArticleYear
The effectiveness of combination therapy with 308-nm excimer laser in vitiligo in Han Chinese People.
    The Australasian journal of dermatology, 2019, Volume: 60, Issue:1

    Topics: Adult; Asian People; Betamethasone; Calcineurin Inhibitors; Combined Modality Therapy; Dermatologic Agents; Female; Humans; Lasers, Excimer; Low-Level Light Therapy; Male; Middle Aged; Skin Pigmentation; Tacrolimus; Vitiligo

2019
The effectiveness of topical therapy combined with 308-nm excimer laser on vitiligo compared to excimer laser monotherapy in pediatric patients.
    Pediatric dermatology, 2019, Volume: 36, Issue:1

    We evaluated the efficiency of using a 308-nm excimer laser with either tacrolimus, pimecrolimus, or halometasone for the treatment of childhood vitiligo. Patients who received combined treatments had significantly higher rates of repigmentation in comparison with individuals who underwent excimer laser alone therapy. Moreover, patients who received treatment with excimer laser and halometasone had significantly higher rates of repigmentation, even higher than individuals who were treated with tacrolimus combined or pimecrolimus combined. This regimen was more effective on the face, neck, and limbs. We conclude that the use of a combined excimer laser and halometasone cream has a greater therapeutic effect than laser alone.

    Topics: Administration, Topical; Betamethasone; Child; Combined Modality Therapy; Dermatologic Agents; Humans; Lasers, Excimer; Prospective Studies; Skin Pigmentation; Tacrolimus; Treatment Outcome; Vitiligo

2019